Diabetes
December 28, 2018
Agile Clinical Research Trials (ACRT) supports Cell & Gene Therapy Clinical Trials focused on evaluating advanced therapies that modify or replace genetic material or cells to treat complex and rare diseases.
These innovative studies require specialized operational oversight, strict regulatory compliance, and precise coordination to ensure subject safety and data integrity.
Our experienced investigators and clinical teams are equipped to support the unique requirements of cell and gene therapy studies, including careful subject monitoring, protocol-specific handling procedures, and accurate documentation aligned with ICH-GCP guidelines and regulatory standards.
Through our access to GMP-certified laboratory infrastructure, we support controlled environments required for handling sensitive biological materials in compliance with quality standards.
ACRT works collaboratively with sponsors and CROs to ensure timely execution of study procedures while maintaining strict adherence to safety, quality, and regulatory expectations.
We support studies involving complex treatment administration processes, biological sample handling coordination, and detailed subject follow-up schedules to ensure reliable evidence generation for regulatory submissions.
Our structured and quality-focused approach ensures that cell and gene therapy clinical trials are conducted with the highest level of precision, safety oversight, and regulatory compliance.